Effects of resveratrol in an animal model of osteoporosis: a meta-analysis of preclinical evidence
Frontiers in Nutrition · 27.07.2023 · 10
DOI: 10.3389/fnut.2023.1234756 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Nutrition, online erschienen am 27.07.2023. Verfasst von Jinlong Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National key research and development program.
Abstract (Originalsprache)
Background
Resveratrol is a natural polyphenol compound that is widely present in herbal medicines such as Reynoutria japonica Houtt. , Veratrum nigrum L. , and Catsiatora Linn and is used in traditional Chinese medicine to treat metabolic bone deseases. Animal experiments have shown that resveratrol may have a strong treatment effect against osteoporosis (OP). The purpose of this study was to explore the efficacy of resveratrol in treating OP animal models based on preclinical research data.
Methods
This study was completed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We searched the PubMed, Embase, Cochrane Library, and China National Knowledge Infrastructure (CNKI) databases from inception to May 8, 2023, to identify animal experiments on the treatment of OP with resveratrol. The effect sizes of bone mineral density (BMD), parameters of micro-CT, serum calcium, phosphorus, alkaline phosphatase (ALP) and osteocalcin were expressed as the mean differences (MDs) and 95% confidence intervals (CIs). RevMan 5.4 software was used for data analysis.
Results
This meta-analysis included a total of 15 animal experiments, including 438 OP rats. The meta-analysis results showed that compared with the control group, resveratrol (<10, 10–25, 40–50, ≥ 60 mg/kg/day) significantly increased femoral and lumbar bone mineral density (BMD) in OP rats ( p < 0.05). Resveratrol (<10 mg/kg/day) significantly increased the BMD of the total body (MD = 0.01, 95% CI: 0.01 to 0.01, p < 0.001). In terms of improving the parameters related to micro-CT, resveratrol (40–50 mg/kg/day) can increase trabecular thickness and trabecular number and reduce trabecular spacing ( p < 0.05). Compared with the control group, resveratrol can reduce the concentration of calcium and phosphorus in serum but has no significant effect on serum ALP and osteocalcin ( p > 0.05). The results of subgroup analysis showed that resveratrol increased the whole-body BMD of SD rats ( p = 0.002) but did not improve the whole-body BMD of 3-month-old rats ( p = 0.17).
Conclusion
Resveratrol can increase BMD in OP rat models, and its mechanism of action may be related to improving bone microstructure and regulating calcium and phosphorus metabolism. The clinical efficacy of resveratrol in the treatment of OP deserves further research.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
- Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
- The Research Team on Bone and Joint Degeneration and Injury of Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou, China.
- The Fifth Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
- Guangdong Second Chinese Medicine Hospital (Guangdong Province Enginering Technology Research Institute of Traditional Chinese Medicine), Guangzhou, China.
Förderung
- National Natural Science Foundation of China
- National key research and development program
Zitieren
APA
Zhao, J., Zhou, G., Yang, J., Pan, J., Sha, B., Luo, M., Yang, W., Liu, J., & Zeng, L. (2023). Effects of resveratrol in an animal model of osteoporosis: a meta-analysis of preclinical evidence. Frontiers in Nutrition, 10. https://doi.org/10.3389/fnut.2023.1234756
Vancouver
Zhao J, Zhou G, Yang J, Pan J, Sha B, Luo M, et al. Effects of resveratrol in an animal model of osteoporosis: a meta-analysis of preclinical evidence. Frontiers in Nutrition. 2023;10. doi:10.3389/fnut.2023.1234756
BibTeX
@article{Zhao2023,
author = {Zhao, Jinlong and Zhou, Guanghui and Yang, Junzheng and Pan, Jianke and Sha, Bangxin and Luo, Minghui and Yang, Weiyi and Liu, Jun and Zeng, Lingfeng},
title = {Effects of resveratrol in an animal model of osteoporosis: a meta-analysis of preclinical evidence},
journal = {Frontiers in Nutrition},
year = {2023},
volume = {10},
doi = {10.3389/fnut.2023.1234756}
}
EUVIMED